Perceived effectiveness of PCSK9i-SiRNA therapy and adherence to background statin therapy: real-world analysis of the DAMAGE registry

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Novel lipid‑lowering therapies for residual risk Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology